Home Online Features "LEQEMBI®" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea
Hand-out
Press Releases
Eisai Inc., Biogen Inc.  
November 28, 2024

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea

TOKYO and CAMBRIDGE, Mass., Nov. 27, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A.

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social